EARNING RECAP

Alibaba Group Holding Ltd

#BABA 2019 EPS:(Actual vs Estimate) Revenue(Actual vs Estimate) Stock price move next bell High Low Notes
Q4 $1.28 est. 96C $13.93B est. $13.32B +1.58% ($177.60 closing price) $180.24 $173.32 Mobile MAUs on China retail marketplace reached 721M up 22M from December 2018; AliExpress &Lazada have 120M annual active customers
Q3 $1.77 est. $1.68 $17.06B est. $17.68B +6.34% ($166.82 closing price) $167.84 $160.50 Q3 cloud revenue up 84% YoY to $962M; MAU on its market place reached 699M an increase of 33M from last quarter; says reform in VAT & other taxes positive for business
Q2 $1.40 est. $1.06 $12.4B est. $12.49B -2.42% ($147.59 closing price) $154.36 $146.28 owers FY19 revenue guidance by 4%-6%, citing macro-economic conditions
Q1 adjusted $1.22 est. $1.21 $12.229B est. $11.5B -3.16% ($172.23 closing) $186.5 $171.91 mobile MAUs in June reached 634M up 17M from March 2018;
#BABA 2018 EPS:(Actual vs Estimate) Revenue(Actual vs Estimate) Stock price move next bell High Low Notes
Q4 adjusted 91c est. 84c $9.87B est. $9.3B +3.53% ($188.89 closing) $190.60 $178.62 e-commerce revenue $8.18B, cloud computing $699M, digital entertainment $840M; sees FY19 revenue $54.56B
Q3 adjusted EPS $1.63 est. $1.67 $12.76B est. $12.68B -5.79% $199.49 $191.14 to take 33% equity stake in ANT financial, raises FY18 revenue growth 55%-56% from 49%-53%; consensus $38.65B; MAU on retail market place 580M in Decemeber up 31M from Sept '17
Q2 adjusted EPS $1.29 Vs $1.03 $8.285B Vs $7.85B -0.68% ($184.81 closing) $191.22 $183.31 raises FY18 revenue grwoth view to 49%-53% from 45%-49%
Q1 63c vs 66c est $5.605B vs $5.23B +0.46% ($121.27 closing) $122.63 $114.00 Initial drops 5%. Stock drops at open but buy the dip to close green. Q4 revenue growth of 60% strongest since IPO. Cloud revenue growth 103%

Please select phase first
Disclaimer! This is NOT an investment advice. The data result herein is purely speculation only. You must do your own due diligence and mitigate your risk. You acknowledge that TradersFish.com will not be held responsible and accountable for any losses you may incur using our Biotech Data Calculator. Please consult your own financial adviser before executing trades.